id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0049-0007,FDA,FDA-2010-E-0049,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T12:50:18Z,,0,0,090000648119d089
FDA-2010-E-0049-0006,FDA,FDA-2010-E-0049,Regulatory Review Period for Purposes of Patent Extension: FERAHEME,Notice,,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,,2012-05-04T13:56:17Z,2012-10849,0,0,090000648100504a
FDA-2010-E-0049-0005,FDA,FDA-2010-E-0049,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T13:16:23Z,,0,0,0900006480ff3390